Publications by authors named "Paul Dorinsky"

Claim this Profile
B
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Mona Bafadhel, Klaus F Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Paul Dorinsky

Int J Chron Obstruct Pulmon Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
Edward Kerwin, Paul Dorinsky, Mehul Patel, Kimberly Rossman, Colin Reisner

J Asthma· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive modeling of COPD exacerbation rates using baseline risk factors.
Dave Singh, John R Hurst, Fernando J Martinez, Klaus F Rabe, Mona Bafadhel, Paul Dorinsky

Ther Adv Respir Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study.
Dave Singh, Klaus F Rabe, Fernando J Martinez, Matthias Krüll, Martin Jenkins, Paul Dorinsky

Respir Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler dual therapies in patients with COPD: a sub-study of the ETHOS trial.
Klaus F Rabe, Fernando J Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins, Paul Dorinsky

Ther Adv Respir Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.
Fernando J Martinez, Alvar Agusti, Bartolome R Celli, MeiLan K Han, James P Allinson, Paul Dorinsky

Am J Respir Crit Care Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, Jadwiga A Wedzicha, Roopa Trivedi, Paul Dorinsky

Respir Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perplexing mortality data from triple therapy trials in COPD - Author's reply.
Fernando J Martinez, Patrick Darken, Paul Dorinsky,

Lancet Respir Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Omar Usmani, Nicolas Roche, Ezanul Wahab, Samuel Israel, Martin Jenkins, Paul Dorinsky

Respir Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.
Rachel Pullen, Marc Miravitlles, Anita Sharma, Dave Singh, Fernando Martinez, Paul Dorinsky

Int J Chron Obstruct Pulmon Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, Paul Dorinsky

Respir Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
Maarten van den Berge, Jan De Backer, Cedric Van Holsbeke, Wilfried De Backer, Roopa Trivedi, Paul Dorinsky

Respir Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.
Fernando J Martinez, Gary T Ferguson, Eric Bourne, Shaila Ballal, Patrick Darken, Paul Dorinsky

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, Paul Dorinsky

Respir Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to López-Campos and to Rogliani and Calzetta.
Fernando J Martinez, Patrick Darken, Paul Dorinsky

Am J Respir Crit Care Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, Jadwiga A Wedzicha, Dave Singh, Paul Dorinsky

Am J Respir Crit Care Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects.
Samuel Israel, Ashish Kumar, Kiernan DeAngelis, Magnus Aurivillius, Paul Dorinsky

Eur J Pharm Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Inhaled Therapy in COPD. Reply.
Klaus F Rabe, Fernando J Martinez, Paul Dorinsky

N Engl J Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects.
Ying Huang, Pryseley Nkouibert Assam, Cong Feng, Rong Su, Paul Dorinsky

Pulm Pharmacol Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between COPD exacerbations and lung function decline during maintenance therapy.
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken

Thorax· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Klaus F Rabe, Fernando J Martinez, Gary T Ferguson, Chen Wang, Dave Singh, Paul Dorinsky

N Engl J Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS.
Chen Wang, Ting Yang, Jian Kang, Rongchang Chen, Li Zhao, Paul Dorinsky

Adv Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
Paul Dorinsky, Paolo DePetrillo, Kiernan DeAngelis, Roopa Trivedi, Patrick Darken

Clin Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD.
Nicola A Hanania, Alberto Papi, Antonio Anzueto, Fernando J Martinez, Kimberly A Rossman, Paul M Dorinsky

ERJ Open Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis